Latest filing published 31 Jan 2023 for Meridian Bioscience INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Tony Serafini-Lamanna: trading record in brief
Tony Serafini-Lamanna (senior executive) discloses dealings in Meridian Bioscience Inc to SEC (Form 4). Between 5 November 2020 and 31 January 2023, the trades on record add up to 10 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 31 January 2023, reports a transaction in Meridian Bioscience Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Tony Serafini-Lamanna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,945 sharesCommon StockSEC:0001567619-23-001527:0
- 3,666 shares@ US$31.8349.4% of flowCommon StockSEC:0001127602-22-025893:0
- 788 shares@ US$32.0111.3% of flowCommon StockSEC:0001127602-22-025088:0
- 357 shares@ US$32.145.0% of flowCommon StockSEC:0001127602-22-023692:0
- 2,232 shares@ US$20.1620.7% of flowCommon StockSEC:0001127602-21-031113:0
- 24,343 sharesCommon StockSEC:0001127602-21-029300:0
- 10,593 shares0Common StockSEC:0001127602-21-028577:0
7 of 7 declarations